Ventavis (iloprost) Inhalation Solution
Recall D-143-2013, part of FDA recall event 64151. See Actelion Pharmaceuticals U.S.'s company page.
Actelion Pharmaceuticals U.S., Inc. started this Class III drug recall on Jan 16, 2013 (voluntary: firm initiated); FDA lists it as terminated, terminated Jul 23, 2013.
- Classification: Class III
- Started: Jan 16, 2013
- Status: Terminated
Subpotent Drug: OOS (out of specification) assay result at the 12 month stability time point.
- Product
- Ventavis (iloprost) Inhalation Solution, 10 mcg/1 mL, Sterile, 30 Single Use Ampules per carton, Manufactured for Actelion Pharmaceuticals US, Inc, 5000 Shoreline Court, Ste 200, South San Francisco, CA 94080, NDC: 66215-302-30.
- Quantity
- 3 Cartons
- Lots and codes
- Lot #: MA00AD5, Exp: 11/30/2014
- Distribution
- CA & VA
- Recalling firm
- Actelion Pharmaceuticals U.S., Inc., South San Francisco, CA, United States
- How the firm notified
- Letter
- FDA classified
- Feb 1, 2013
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports